Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exploring sensory sensitivity, cortical excitability, and habituation in episodic migraine, as a function of age and disease severity, using the pattern-reversal task

  • Marti-Marca, Angela|||0000-0002-9041-2943
  • Vilà-Balló, Adrià|||0000-0001-7593-6012
  • Cerdá Company, Xim|||0000-0001-7359-5453
  • Ikumi, Nara
  • Torres-Ferrús, Marta|||0000-0003-2856-4134
  • Caronna, Edoardo|||0000-0001-5525-0267
  • Alpuente, Alicia|||0000-0001-5296-9401
  • Torralba Cuello, Mireia
  • Soto-Faraco, Salvador|||0000-0002-4799-3762
  • Pozo-Rosich, Patricia|||0000-0003-0796-4702
  • Gallardo López, Victor José|||0000-0002-3042-2007
Migraine is a cyclic, neurosensory disorder characterized by recurrent headaches and altered sensory processing. The latter is manifested in hypersensitivity to visual stimuli, measured with questionnaires and sensory thresholds, as well as in abnormal cortical excitability and a lack of habituation, assessed with visual evoked potentials elicited by pattern-reversal stimulation. Here, the goal was to determine whether factors such as age and/or disease severity may exert a modulatory influence on sensory sensitivity, cortical excitability, and habituation. Two similar experiments were carried out, the first comparing 24 young, episodic migraine patients and 28 healthy age- and gender-matched controls and the second 36 middle-aged, episodic migraine patients and 30 healthy age- and gender-matched controls. A neurologist confirmed the diagnoses. Migraine phases were obtained using eDiaries. Sensory sensitivity was assessed with the Sensory Perception Quotient and group comparisons were carried out. We obtained pattern-reversal visual evoked potentials and calculated the N1-P1 Peak-to-Peak amplitude. Two linear mixed-effects models were fitted to these data. The first model had Block (first block, last block) and Group (patients, controls) as fixed factors, whereas the second model had Trial (all trials) and Group as fixed factors. Participant was included as a random factor in both. N1-P1 first block amplitude was used to assess cortical excitability and habituation was defined as a decrease of N1-P1 amplitude across Blocks/Trials. Both experiments were performed interictally. The final samples consisted of 18 patients with episodic migraine and 27 headache-free controls (first experiment) and 19 patients and 29 controls (second experiment). In both experiments, patients reported increased visual hypersensitivity on the Sensory Perception Quotient as compared to controls. Regarding N1-P1 peak-to-peak data, there was no main effect of Group, indicating no differences in cortical excitability between groups. Finally, significant main effects of both Block and Trial were found indicating habituation in both groups, regardless of age and headache frequency. The results of this study yielded evidence for significant hypersensitivity in patients but no significant differences in either habituation or cortical excitability, as compared to headache-free controls. Although the alterations in patients may be less pronounced than originally anticipated they demonstrate the need for the definition and standardization of optimal methodological parameters.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Quantifying sensory thresholds along the migraine cycle: An exploratory longitudinal study

  • De la Torre Suñe, Anna
  • Cerda-Company, Xim
  • Vilà-Balló, Adrià
  • Ikumi, Nara
  • Marti Marca, Angela
  • Gallardo López, Víctor J.
  • Caronna, Edoardo
  • Alpuente Ruiz, Alicia
  • Pozo-Rosich, Patricia
Allodynia; Osmophobia; Phonophobia, Alodínia; Osmofòbia; Fonofòbia, Alodinia; Osmofobia; Fonofobia, Background To date, a number of studies on migraine have cross-sectionally evaluated sensory sensitivity with aversion thresholds/scores along the migraine cycle, reporting a decreased tolerance to sensory stimuli in different sensory modalities. Our hypothesis was that patients with migraine would exhibit heightened sensitivity to sound, light, touch and smell on days where they reported greater headache intensity. Methods This is an exploratory, longitudinal study, carried out over the course of 27 days. Aversion thresholds or scores to sound, light, touch and smell were quantified in six patients with migraine (11.33 ± 6.53 headache days/month). Results Patients reported an increased sensitivity to light (padj = 0.0297), touch (padj = 0.0077), and smell (padj = 0.0201) on days with higher headache intensity. However, a greater sensitivity to sound on days with higher headache intensity was only reported when anxiety levels were high (padj = 1.4e−06). Interestingly, variable levels of tolerance to bothersome light over time can also influence the correlation between light sensitivity and headache intensity (padj = 1.4e−06). Conclusions Based on the present findings, future longitudinal studies evaluating sensory threshold changes along the migraine cycle in patients with migraine should account for the increased tolerance to bothersome light over time as well as the effect of anxiety on auditory sensitivity., The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: NI salary has been co-funded by the European Regional Development Fund (001-P-001682) under the framework of the FEDER Operative Programme for Catalunya 2014–2020, with €1,527,637.88. AMM salary has been partially financed by a predoctoral grant from the “Fundació Institut de Recerca Hospital Universitari Vall d’Hebron” (VHIR/BEQUESPREDOC/2020/MARTI). AVB salary has been partially financed by a Juan de la Cierva-Formación grant (FJC2018-036804-I) and Juan de la Cierva – Incorporación postdoctoral (IJC2020-043139-I) from the Spanish Ministry of Science and Innovation. EC salary has been funded by Río Hortega grant Acción Estratégica en Salud 2017–2020, instituto de Salud Carlos III (CM20/00217).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Guidelines of the International Headache Society for Real-World Evidence studies in migraine and cluster headache

  • van Veelen, Nancy
  • van der Arend, Britt
  • Pozo-Rosich, Patricia
  • Caronna, Edoardo
  • Vaghi, Gloria
  • TORRES-FERRUS, MARTA
Adverse event; Patient reported outcome measures; Real world evidence, Evento adverso; Medidas de resultados informadas por el paciente; Evidencia del mundo real, Esdeveniment advers; Mesures de resultat informades pel pacient; Evidència del món real, Real-world evidence studies are an important tool for investigating the effectiveness, safety and tolerability of treatments for headache disorders in clinical practice. These studies use data generated from routine clinical practice from a variety of sources and can help to identify unmet needs in headache care and guide new therapies, including populations not always included in randomized clinical trials of different ages, comorbidities, and concomitant stable treatments. Real-world evidence pertains to the clinical evidence surrounding the utilization, as well as the potential advantages or drawbacks of treatment, which is extracted through an analysis of real-world data. Real-world evidence studies can present unique challenges, including timing of data collection (prospective vs retrospective), data selection, data quality issues and potential biases (selection, confounding factors, etc.). The International Headache Society has developed these guidelines for optimizing the design and conduct of real-world evidence studies, and therefore the strength and reliability of their output.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Optimizing Chronic Migraine Care: The Impact of Advanced Practice Nurse Involvement in OnabotulinumtoxinA Administration

  • Gine-Cipres, Eulalia
  • Gallardo López, Víctor J.
  • TORRES-FERRUS, MARTA
  • Alpuente Ruiz, Alicia
  • Caronna, Edoardo
  • Gómez Dabó, Laura
  • Pozo-Rosich, Patricia
Advanced practice nursing; Botulinum toxin type A; Headache, Infermeria de pràctica avançada; Toxina botulínica tipus A; Mal de cap, Enfermería de práctica avanzada; Toxina botulínica tipo A; Dolor de cabeza, Background: Chronic migraine is a disabling and prevalent neurological disease that significantly impacts patients' quality of life. OnabotulinumtoxinA (OnabotA) is a safe and effective chronic migraine preventive treatment. The objective was to evaluate adherence to the recommended time interval between consecutive OnabotA injections according to the Phase III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) protocol, and to analyze changes in the interval adherence before and after the introduction of an Advanced Practice Nurse (APN) in a specialized Headache Unit of a tertiary hospital. Methods: This was a retrospective study performed in a Spanish specialized Headache Clinic. Patients diagnosed with chronic migraine and treated with OnabotA following the PREEMPT protocol were included, before and after the introduction of APNs. Treatment was considered interval-compliant if the injection interval ranged from 75 to 105 days. The data collected included three 18-month periods. Statistical analyses examined differences across periods using R-Studio. Results: A total of 2991 participants were included, of whom 83.8% (2507/2991) were women, with a median age [interquartile range (IQR)] of 48.0 [40.0–57.0] years old. A statistically significant association between the introduction of the APN and improved adherence to the PREEMPT protocol was observed over time (Z = –19.60, p < 0.001). Adherence rates increased from 52.1% in P1 to 76.1% in both P2 and P3. The median time between visits decreased from 105 days in P1 to 96 days in P2, with a slight increase to 98 days in P3. Conclusion: The involvement of advanced practice nurses in OnabotA administration decreased the time interval between infiltrations and improved adherence to the PREEMPT protocol. These findings highlight the APN's role in optimizing patient care.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Neck pain in migraine: A narrative review and steps to correct evaluation and treatment

  • Rees, Tayla
  • Doukhi, Diana
  • Wang, Victor S
  • Balcerbula, Anita
  • Bravo, Michelle
  • fathi, haniyeh
  • Caronna, Edoardo
  • Pozo-Rosich, Patricia
Evaluation; Migraine; Neck pain, Avaluació; Migranya; Dolor cervical, Evaluación; Migraña; Dolor cervical, Background Neck pain is common in migraine patients, occurring during all migraine phases and between attacks. It can be a migraine symptom, trigger or a coexisting condition, and is associated with greater disability and poorer treatment response. There is evidence that neck pain associated with headaches can be frequently incorrectly diagnosed as a cervical disorder rather than migraine, resulting in a lack of appropriate treatment. Accurately assessing the connection between neck pain and migraine is crucial for effective treatment. Methods This narrative review aims to summarise existing research on the role and contribution of neck pain in migraine, both as a symptom and a trigger, and outlines future research needed to deepen our understanding of this relationship. It also proposes a structured approach for assessing neck pain in migraine and a treatment algorithm, offering guidance for clinical evaluation and treatment. For this purpose, a comprehensive narrative review was conducted using PubMed, covering preclinical, clinical, neurophysiological and imaging evidence on migraine and neck pain. Results Migraine patients frequently exhibit cervical dysfunction, tenderness and altered posture, with overlapping neuroanatomical pathways of the neck and trigeminal systems, suggesting shared mechanisms of nociception and migraine initiation. Clinical assessment involves a thorough history, physical exam and exclusion of secondary causes. Standard migraine therapies, such as amitriptyline and onabotulinumtoxinA, may help reduce neck pain and non-pharmacological treatments, such as physical therapy, acupuncture and behavioural strategies, show some promise. However, evidence on neck pain relief is limited. Conclusions Accurately distinguishing whether neck pain is a symptom, trigger or comorbid condition in migraine is essential for guiding effective treatment strategies. Both pharmacological and non-pharmacological approaches may help manage migraine-associated neck pain. However, few studies have assessed the effects of acute or preventive migraine therapies, particularly calcitonin gene-related peptide-targeted treatments, on neck pain, highlighting a significant gap in our current knowledge. Future research should evaluate the effectiveness of these therapies on neck pain, both alone and in combination with non-pharmacological interventions., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: TAR acknowledges receipt of the International Headache Society Fellowship from the International Headache Society. EC’s salary has been partially funded by Río Hortega grant Acción Estratégica en Salud 2017–2020 from Instituto de Salud Carlos III (CM20/00217) and Juan Rodés fellowship, Subprograma Estatal de Incorporación de la Acción Estratégica en Salud 2023 (JR23/00065).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Exploring sensory sensitivity, cortical excitability, and habituation in episodic migraine, as a function of age and disease severity, using the pattern-reversal task

  • Marti Marca, Angela
  • Vila Ballo, Adria
  • Cerda-Company, Xim
  • Ikumi, Nara
  • TORRES-FERRUS, MARTA
  • Caronna, Edoardo
  • Gallardo López, Víctor J.
  • Alpuente Ruiz, Alicia
  • Pozo-Rosich, Patricia
Cortical excitability; Migraine; Visual sensitivity, Excitabilitat cortical; Migranya; Sensibilitat visual, Excitabilidad cortical; Migraña; Sensibilidad visual, Background Migraine is a cyclic, neurosensory disorder characterized by recurrent headaches and altered sensory processing. The latter is manifested in hypersensitivity to visual stimuli, measured with questionnaires and sensory thresholds, as well as in abnormal cortical excitability and a lack of habituation, assessed with visual evoked potentials elicited by pattern-reversal stimulation. Here, the goal was to determine whether factors such as age and/or disease severity may exert a modulatory influence on sensory sensitivity, cortical excitability, and habituation. Methods Two similar experiments were carried out, the first comparing 24 young, episodic migraine patients and 28 healthy age- and gender-matched controls and the second 36 middle-aged, episodic migraine patients and 30 healthy age- and gender-matched controls. A neurologist confirmed the diagnoses. Migraine phases were obtained using eDiaries. Sensory sensitivity was assessed with the Sensory Perception Quotient and group comparisons were carried out. We obtained pattern-reversal visual evoked potentials and calculated the N1-P1 Peak-to-Peak amplitude. Two linear mixed-effects models were fitted to these data. The first model had Block (first block, last block) and Group (patients, controls) as fixed factors, whereas the second model had Trial (all trials) and Group as fixed factors. Participant was included as a random factor in both. N1-P1 first block amplitude was used to assess cortical excitability and habituation was defined as a decrease of N1-P1 amplitude across Blocks/Trials. Both experiments were performed interictally. Results The final samples consisted of 18 patients with episodic migraine and 27 headache-free controls (first experiment) and 19 patients and 29 controls (second experiment). In both experiments, patients reported increased visual hypersensitivity on the Sensory Perception Quotient as compared to controls. Regarding N1-P1 peak-to-peak data, there was no main effect of Group, indicating no differences in cortical excitability between groups. Finally, significant main effects of both Block and Trial were found indicating habituation in both groups, regardless of age and headache frequency. Conclusions The results of this study yielded evidence for significant hypersensitivity in patients but no significant differences in either habituation or cortical excitability, as compared to headache-free controls. Although the alterations in patients may be less pronounced than originally anticipated they demonstrate the need for the definition and standardization of optimal methodological parameters., The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: AMM salary has been partially financed by a predoctoral grant from the “Fundacio Institut de Recerca Hospital Universitari Vall d’Hebron” (VHIR/BEQUESPREDOC/2020/MARTI). AVB salary has been partially financed by a Juan de la Cierva-Formacion grant (FJC2018-036804-I) and a Juan de la Cierva-Incorporación grant (IJC2020-043139-I) from the Spanish Ministry of Science and Innovation. XCC salary has been co-funded by the European Regional Development Fund (001-P-001682) under the framework of the FEDER Operative Programme for Catalunya 2014–2020, with 1,527,637.88 euros. EC salary has been funded by Rıo Hortega grant Accion Estrategica en Salud 2017–2020, Instituto de Salud Carlos III (CM20/00217). SSF has been supported by grants from the Ministerio de Ciencia e Innovación (PID2019-108531 GB-I00 AEI/FEDER) and AGAUR Generalitat de Catalunya (2021 SGR 00911). The project leading to these results has received funding from “la Caixa” Foundation under the project code “LCF/PR/PR16/51110005”.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Early treatment in migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society

  • Özge, Aynur
  • Pozo-Rosich, Patricia
  • Caronna, Edoardo
  • Sacco, Simona
  • Peres, Mario F P
  • Ashina, Sait
Anti-CGRP therapies; Migraine preventive treatment; Preventive treatment, Terapias anti-CGRP; Tratamiento preventivo de la migraña; Tratamiento preventivo, Teràpies anti-CGRP; Tractament preventiu de la migranya; Tractament preventiu, Migraine is one of the most disabling diseases worldwide, especially when it transforms into chronic migraine, which is often associated with medication overuse and can become resistant or even refractory to treatments. Molecular, neuroimaging and neurophysiological changes have been described in chronic migraine, some of which might not be fully reversible with preventive treatment. For these reasons, we should aim to prevent this transition, and initiate preventive treatment before disease becomes refractory and burden increases. Preventive migraine treatments are often delayed because of access to care, stigma leading to undertreatment and patients' reluctance as a result of fear of side effects and, in some cases, fear of being labeled as chronically ill. With the availability of effective and well-tolerated preventive treatments, we must shift our mindset and take advantage of new opportunities to initiate preventive treatment earlier. In this International Headache Society position statement, we propose a migraine preventive strategy under the idea of shifting from reactive treatment once disability is established (prevention of attacks), to proactive, individualized prevention initiated early with safe, effective and tolerable therapies (prevention of disease progression). This approach is based on 1) promoting the early initiation of effective and tolerable preventive therapies, starting from two to four monthly migraine days in line with the majority of current guidelines and recommendations and 2) fostering longitudinal studies to gather more evidence on the potential benefit of early prevention, with the final goal of improving patient outcomes, promoting excellent migraine care, enhancing individual and social well-being, and, ultimately, preventing migraine progression and preserving brain health., EC has received honoraria from Novartis, Chiesi, Lundbeck, MedScape, Lilly, TEVA, Organon and Dr Reddy's; his salary has been partially funded by Río Hortega grant Acción Estratégica en Salud 2017–2020 from Instituto de Salud Carlos III (CM20/00217) and Juan Rodés fellowship, Subprograma Estatal de Incorporación de la Acción Estratégica en Salud 2023 (JR23/00065). He is a junior editor for Cephalalgia.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Exploring sensory sensitivity, cortical excitability, and habituation in episodic migraine, as a function of age and disease severity, using the pattern-reversal task

  • Marti Marca, Angela
  • Vila Ballo, Adria
  • Cerda-Company, Xim
  • Ikumi, Nara
  • TORRES-FERRUS, MARTA
  • Caronna, Edoardo
  • Gallardo López, Víctor J.
  • Alpuente Ruiz, Alicia
  • Pozo-Rosich, Patricia
Cortical excitability; Migraine; Visual sensitivity, Excitabilitat cortical; Migranya; Sensibilitat visual, Excitabilidad cortical; Migraña; Sensibilidad visual, Background Migraine is a cyclic, neurosensory disorder characterized by recurrent headaches and altered sensory processing. The latter is manifested in hypersensitivity to visual stimuli, measured with questionnaires and sensory thresholds, as well as in abnormal cortical excitability and a lack of habituation, assessed with visual evoked potentials elicited by pattern-reversal stimulation. Here, the goal was to determine whether factors such as age and/or disease severity may exert a modulatory influence on sensory sensitivity, cortical excitability, and habituation. Methods Two similar experiments were carried out, the first comparing 24 young, episodic migraine patients and 28 healthy age- and gender-matched controls and the second 36 middle-aged, episodic migraine patients and 30 healthy age- and gender-matched controls. A neurologist confirmed the diagnoses. Migraine phases were obtained using eDiaries. Sensory sensitivity was assessed with the Sensory Perception Quotient and group comparisons were carried out. We obtained pattern-reversal visual evoked potentials and calculated the N1-P1 Peak-to-Peak amplitude. Two linear mixed-effects models were fitted to these data. The first model had Block (first block, last block) and Group (patients, controls) as fixed factors, whereas the second model had Trial (all trials) and Group as fixed factors. Participant was included as a random factor in both. N1-P1 first block amplitude was used to assess cortical excitability and habituation was defined as a decrease of N1-P1 amplitude across Blocks/Trials. Both experiments were performed interictally. Results The final samples consisted of 18 patients with episodic migraine and 27 headache-free controls (first experiment) and 19 patients and 29 controls (second experiment). In both experiments, patients reported increased visual hypersensitivity on the Sensory Perception Quotient as compared to controls. Regarding N1-P1 peak-to-peak data, there was no main effect of Group, indicating no differences in cortical excitability between groups. Finally, significant main effects of both Block and Trial were found indicating habituation in both groups, regardless of age and headache frequency. Conclusions The results of this study yielded evidence for significant hypersensitivity in patients but no significant differences in either habituation or cortical excitability, as compared to headache-free controls. Although the alterations in patients may be less pronounced than originally anticipated they demonstrate the need for the definition and standardization of optimal methodological parameters., The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: AMM salary has been partially financed by a predoctoral grant from the “Fundacio Institut de Recerca Hospital Universitari Vall d’Hebron” (VHIR/BEQUESPREDOC/2020/MARTI). AVB salary has been partially financed by a Juan de la Cierva-Formacion grant (FJC2018-036804-I) and a Juan de la Cierva-Incorporación grant (IJC2020-043139-I) from the Spanish Ministry of Science and Innovation. XCC salary has been co-funded by the European Regional Development Fund (001-P-001682) under the framework of the FEDER Operative Programme for Catalunya 2014–2020, with 1,527,637.88 euros. EC salary has been funded by Rıo Hortega grant Accion Estrategica en Salud 2017–2020, Instituto de Salud Carlos III (CM20/00217). SSF has been supported by grants from the Ministerio de Ciencia e Innovación (PID2019-108531 GB-I00 AEI/FEDER) and AGAUR Generalitat de Catalunya (2021 SGR 00911). The project leading to these results has received funding from “la Caixa” Foundation under the project code “LCF/PR/PR16/51110005”.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Quantifying sensory thresholds along the migraine cycle: An exploratory longitudinal study

  • De la Torre Suñe, Anna
  • Cerda-Company, Xim
  • Vilà-Balló, Adrià
  • Ikumi, Nara
  • Marti Marca, Angela
  • Gallardo López, Víctor J.
  • Caronna, Edoardo
  • Alpuente Ruiz, Alicia
  • Pozo-Rosich, Patricia
Allodynia; Osmophobia; Phonophobia, Alodínia; Osmofòbia; Fonofòbia, Alodinia; Osmofobia; Fonofobia, Background To date, a number of studies on migraine have cross-sectionally evaluated sensory sensitivity with aversion thresholds/scores along the migraine cycle, reporting a decreased tolerance to sensory stimuli in different sensory modalities. Our hypothesis was that patients with migraine would exhibit heightened sensitivity to sound, light, touch and smell on days where they reported greater headache intensity. Methods This is an exploratory, longitudinal study, carried out over the course of 27 days. Aversion thresholds or scores to sound, light, touch and smell were quantified in six patients with migraine (11.33 ± 6.53 headache days/month). Results Patients reported an increased sensitivity to light (padj = 0.0297), touch (padj = 0.0077), and smell (padj = 0.0201) on days with higher headache intensity. However, a greater sensitivity to sound on days with higher headache intensity was only reported when anxiety levels were high (padj = 1.4e−06). Interestingly, variable levels of tolerance to bothersome light over time can also influence the correlation between light sensitivity and headache intensity (padj = 1.4e−06). Conclusions Based on the present findings, future longitudinal studies evaluating sensory threshold changes along the migraine cycle in patients with migraine should account for the increased tolerance to bothersome light over time as well as the effect of anxiety on auditory sensitivity., The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: NI salary has been co-funded by the European Regional Development Fund (001-P-001682) under the framework of the FEDER Operative Programme for Catalunya 2014–2020, with €1,527,637.88. AMM salary has been partially financed by a predoctoral grant from the “Fundació Institut de Recerca Hospital Universitari Vall d’Hebron” (VHIR/BEQUESPREDOC/2020/MARTI). AVB salary has been partially financed by a Juan de la Cierva-Formación grant (FJC2018-036804-I) and Juan de la Cierva – Incorporación postdoctoral (IJC2020-043139-I) from the Spanish Ministry of Science and Innovation. EC salary has been funded by Río Hortega grant Acción Estratégica en Salud 2017–2020, instituto de Salud Carlos III (CM20/00217).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Early treatment in migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society

  • Özge, Aynur
  • Pozo-Rosich, Patricia
  • Caronna, Edoardo
  • Sacco, Simona
  • Peres, Mario F P
  • Ashina, Sait
Anti-CGRP therapies; Migraine preventive treatment; Preventive treatment, Terapias anti-CGRP; Tratamiento preventivo de la migraña; Tratamiento preventivo, Teràpies anti-CGRP; Tractament preventiu de la migranya; Tractament preventiu, Migraine is one of the most disabling diseases worldwide, especially when it transforms into chronic migraine, which is often associated with medication overuse and can become resistant or even refractory to treatments. Molecular, neuroimaging and neurophysiological changes have been described in chronic migraine, some of which might not be fully reversible with preventive treatment. For these reasons, we should aim to prevent this transition, and initiate preventive treatment before disease becomes refractory and burden increases. Preventive migraine treatments are often delayed because of access to care, stigma leading to undertreatment and patients' reluctance as a result of fear of side effects and, in some cases, fear of being labeled as chronically ill. With the availability of effective and well-tolerated preventive treatments, we must shift our mindset and take advantage of new opportunities to initiate preventive treatment earlier. In this International Headache Society position statement, we propose a migraine preventive strategy under the idea of shifting from reactive treatment once disability is established (prevention of attacks), to proactive, individualized prevention initiated early with safe, effective and tolerable therapies (prevention of disease progression). This approach is based on 1) promoting the early initiation of effective and tolerable preventive therapies, starting from two to four monthly migraine days in line with the majority of current guidelines and recommendations and 2) fostering longitudinal studies to gather more evidence on the potential benefit of early prevention, with the final goal of improving patient outcomes, promoting excellent migraine care, enhancing individual and social well-being, and, ultimately, preventing migraine progression and preserving brain health., EC has received honoraria from Novartis, Chiesi, Lundbeck, MedScape, Lilly, TEVA, Organon and Dr Reddy's; his salary has been partially funded by Río Hortega grant Acción Estratégica en Salud 2017–2020 from Instituto de Salud Carlos III (CM20/00217) and Juan Rodés fellowship, Subprograma Estatal de Incorporación de la Acción Estratégica en Salud 2023 (JR23/00065). He is a junior editor for Cephalalgia.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Optimizing Chronic Migraine Care: The Impact of Advanced Practice Nurse Involvement in OnabotulinumtoxinA Administration

  • Gine-Cipres, Eulalia
  • Gallardo López, Víctor J.
  • TORRES-FERRUS, MARTA
  • Alpuente Ruiz, Alicia
  • Caronna, Edoardo
  • Gómez Dabó, Laura
  • Pozo-Rosich, Patricia
Advanced practice nursing; Botulinum toxin type A; Headache, Infermeria de pràctica avançada; Toxina botulínica tipus A; Mal de cap, Enfermería de práctica avanzada; Toxina botulínica tipo A; Dolor de cabeza, Background: Chronic migraine is a disabling and prevalent neurological disease that significantly impacts patients' quality of life. OnabotulinumtoxinA (OnabotA) is a safe and effective chronic migraine preventive treatment. The objective was to evaluate adherence to the recommended time interval between consecutive OnabotA injections according to the Phase III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) protocol, and to analyze changes in the interval adherence before and after the introduction of an Advanced Practice Nurse (APN) in a specialized Headache Unit of a tertiary hospital. Methods: This was a retrospective study performed in a Spanish specialized Headache Clinic. Patients diagnosed with chronic migraine and treated with OnabotA following the PREEMPT protocol were included, before and after the introduction of APNs. Treatment was considered interval-compliant if the injection interval ranged from 75 to 105 days. The data collected included three 18-month periods. Statistical analyses examined differences across periods using R-Studio. Results: A total of 2991 participants were included, of whom 83.8% (2507/2991) were women, with a median age [interquartile range (IQR)] of 48.0 [40.0–57.0] years old. A statistically significant association between the introduction of the APN and improved adherence to the PREEMPT protocol was observed over time (Z = –19.60, p < 0.001). Adherence rates increased from 52.1% in P1 to 76.1% in both P2 and P3. The median time between visits decreased from 105 days in P1 to 96 days in P2, with a slight increase to 98 days in P3. Conclusion: The involvement of advanced practice nurses in OnabotA administration decreased the time interval between infiltrations and improved adherence to the PREEMPT protocol. These findings highlight the APN's role in optimizing patient care.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Neck pain in migraine: A narrative review and steps to correct evaluation and treatment

  • Rees, Tayla
  • Doukhi, Diana
  • Wang, Victor S
  • Balcerbula, Anita
  • Bravo, Michelle
  • fathi, haniyeh
  • Caronna, Edoardo
  • Pozo-Rosich, Patricia
Evaluation; Migraine; Neck pain, Avaluació; Migranya; Dolor cervical, Evaluación; Migraña; Dolor cervical, Background Neck pain is common in migraine patients, occurring during all migraine phases and between attacks. It can be a migraine symptom, trigger or a coexisting condition, and is associated with greater disability and poorer treatment response. There is evidence that neck pain associated with headaches can be frequently incorrectly diagnosed as a cervical disorder rather than migraine, resulting in a lack of appropriate treatment. Accurately assessing the connection between neck pain and migraine is crucial for effective treatment. Methods This narrative review aims to summarise existing research on the role and contribution of neck pain in migraine, both as a symptom and a trigger, and outlines future research needed to deepen our understanding of this relationship. It also proposes a structured approach for assessing neck pain in migraine and a treatment algorithm, offering guidance for clinical evaluation and treatment. For this purpose, a comprehensive narrative review was conducted using PubMed, covering preclinical, clinical, neurophysiological and imaging evidence on migraine and neck pain. Results Migraine patients frequently exhibit cervical dysfunction, tenderness and altered posture, with overlapping neuroanatomical pathways of the neck and trigeminal systems, suggesting shared mechanisms of nociception and migraine initiation. Clinical assessment involves a thorough history, physical exam and exclusion of secondary causes. Standard migraine therapies, such as amitriptyline and onabotulinumtoxinA, may help reduce neck pain and non-pharmacological treatments, such as physical therapy, acupuncture and behavioural strategies, show some promise. However, evidence on neck pain relief is limited. Conclusions Accurately distinguishing whether neck pain is a symptom, trigger or comorbid condition in migraine is essential for guiding effective treatment strategies. Both pharmacological and non-pharmacological approaches may help manage migraine-associated neck pain. However, few studies have assessed the effects of acute or preventive migraine therapies, particularly calcitonin gene-related peptide-targeted treatments, on neck pain, highlighting a significant gap in our current knowledge. Future research should evaluate the effectiveness of these therapies on neck pain, both alone and in combination with non-pharmacological interventions., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: TAR acknowledges receipt of the International Headache Society Fellowship from the International Headache Society. EC’s salary has been partially funded by Río Hortega grant Acción Estratégica en Salud 2017–2020 from Instituto de Salud Carlos III (CM20/00217) and Juan Rodés fellowship, Subprograma Estatal de Incorporación de la Acción Estratégica en Salud 2023 (JR23/00065).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Guidelines of the International Headache Society for Real-World Evidence studies in migraine and cluster headache

  • van Veelen, Nancy
  • van der Arend, Britt
  • Pozo-Rosich, Patricia
  • Caronna, Edoardo
  • Vaghi, Gloria
  • TORRES-FERRUS, MARTA
Adverse event; Patient reported outcome measures; Real world evidence, Evento adverso; Medidas de resultados informadas por el paciente; Evidencia del mundo real, Esdeveniment advers; Mesures de resultat informades pel pacient; Evidència del món real, Real-world evidence studies are an important tool for investigating the effectiveness, safety and tolerability of treatments for headache disorders in clinical practice. These studies use data generated from routine clinical practice from a variety of sources and can help to identify unmet needs in headache care and guide new therapies, including populations not always included in randomized clinical trials of different ages, comorbidities, and concomitant stable treatments. Real-world evidence pertains to the clinical evidence surrounding the utilization, as well as the potential advantages or drawbacks of treatment, which is extracted through an analysis of real-world data. Real-world evidence studies can present unique challenges, including timing of data collection (prospective vs retrospective), data selection, data quality issues and potential biases (selection, confounding factors, etc.). The International Headache Society has developed these guidelines for optimizing the design and conduct of real-world evidence studies, and therefore the strength and reliability of their output.